Polycystic ovary syndrome: a review for primary providers

被引:7
作者
Buccola, JM
Reynolds, EE
机构
[1] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Internal Med Residency Program, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源
PRIMARY CARE | 2003年 / 30卷 / 04期
关键词
D O I
10.1016/S0095-4543(03)00089-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Clinical case: A 17-year-old presents in transfer from her pediatrician. She reports no health problems, but her mother is worried about her weight, which has been high since menarche at 13. Her menses, about three times per year, are heavy and unpredictable in timing but are not associated with cramping or pain. Her BMI is 29, and she has mild acne and some hair growth around her nipples. Is this normal? Should she be evaluated for polycystic ovary syndrome (PCOS)? Do you need to order any tests? How should she be treated?
引用
收藏
页码:697 / +
页数:15
相关论文
共 46 条
[1]   PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J].
ADAMS, J ;
POLSON, DW ;
FRANKS, S .
BRITISH MEDICAL JOURNAL, 1986, 293 (6543) :355-359
[2]   Cardiovascular consequences of polycystic ovary syndrome [J].
Amowitz, LL ;
Sobel, BE .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1999, 28 (02) :439-+
[3]   A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[4]  
BARBIERI RL, 1984, OBSTET GYNECOL, V64, P73
[5]   SPIRONOLACTONE IS AN EFFECTIVE AND WELL TOLERATED SYSTEMIC ANTIANDROGEN THERAPY FOR HIRSUTE WOMEN [J].
BARTH, JH ;
CHERRY, CA ;
WOJNAROWSKA, F ;
DAWBER, RPR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (05) :966-970
[6]   Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization [J].
Birdsall, MA ;
Farquhar, CM ;
White, HD .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (01) :32-35
[7]   REPRODUCTIVE, MENSTRUAL, AND MEDICAL RISK-FACTORS FOR ENDOMETRIAL CANCER - RESULTS FROM A CASE-CONTROL STUDY [J].
BRINTON, LA ;
BERMAN, ML ;
MORTEL, R ;
TWIGGS, LB ;
BARRETT, RJ ;
WILBANKS, GD ;
LANNOM, L ;
HOOVER, RN .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (05) :1317-1325
[8]   CORRELATION OF HYPERANDROGENISM WITH HYPERINSULINISM IN POLYCYSTIC OVARIAN DISEASE [J].
BURGHEN, GA ;
GIVENS, JR ;
KITABCHI, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (01) :113-116
[9]  
Buyalos RP, 1996, FERTIL STERIL, V65, P1
[10]   DOES ETHNICITY INFLUENCE THE PREVALENCE OF ADRENAL HYPERANDROGENISM AND INSULIN RESISTANCE IN POLYCYSTIC-OVARY-SYNDROME [J].
CARMINA, E ;
KOYAMA, T ;
CHANG, L ;
STANCZYK, FZ ;
LOBO, RA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (06) :1807-1812